자본잠식 — 자본총계가 마이너스입니다. 부실 위험을 나타내는 사실 지표입니다.
Rain Therapeutics
RAIN · NasdaqRain Therapeutics last closed at $0.8512 (-1.66%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.
New high + volume — the real recordrecord · not a prediction
Every new-high-plus-volume pick we actually published (US market) — not this stock alone.
Trade plan
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
A calculator · not advice or a guarantee
Financials & valuation at a glance
Past reported results · not investment advice
More — deeper indicators
Financial safety
Reference indicatorAs of 2024- Altman Z''
- -68.52
- Beneish M-Score
- —
- Sloan accrual
- -251.58%
Statistical flag unavailable
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
Piotroski measures year-over-year financial improvement, not absolute quality.
Profitability
- Positive ROANot passed
- Positive OCFNot passed
- Improving ΔROANot passed
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioNot passed
- No new sharesNot passed
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
영업이익률 악화 (10.8% → -1.7%, -12.5%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
영업외손익 급변 (영업이익 대비 385% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
Connections
AI-extracted related companies · for reference
Recent filings
Filings for overseas stocks are on the way. For now we cover Korean stocks only.
About Rain Therapeutics
- What technical signals does Rain Therapeutics (RAIN) have?
- Rain Therapeutics current technical signals: no active technical signal.
- Is Rain Therapeutics a cup-and-handle pattern?
- No. Rain Therapeutics has no valid cup-and-handle signal right now.
- What are Rain Therapeutics's financials and valuation?
- Rain Therapeutics's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Quantus Signal · live data · not investment advice · Privacy Policy